KNEE TREATMENTS Knee Surgery Alternative Knee Arthritis & OsteoarthritisKnee Meniscus Tear Treatment FOOT, TOE & ANKLE TREATMENTS Plantar FasciitisAnkle Ligament TearsArthritis & OsteoarthritisAnkle Tendon Tears SHOULDER TREATMENTS Shoulder Surgery AlternativeRotator Cuff TearShoulder Labrum SLAP TearShoulder Arthritis TreatmentShoulder ImpingementFrozen Shoulder AESTHETIC TREATMENTS MicroneedlingHair Loss TreatmentFacial Rejuvenation procedures – Regenerative Stem Cell TherapyWrinkle Treatment HIP TREATMENTS Hip Surgery AlternativesHip Arthritis & OsteoarthritisHip BursitisHip Labrum Tear ELBOW TREATMENTS Elbow Surgery AlternativeElbow BursitisTennis & Golfer’s ElbowElbow Arthritis & Osteoarthritis HAND & WRIST TREATMENTS Thumb OsteoarthritisTrigger Thumb/FingerDe Quervains TenosynovitisRadial tenosynovitis/ Gamers Thumb BACK PAIN TREATMENT Back Pain JOINT PRESERVATION TREATMENT Joint Preservation/Joint Care SPORTS INJURY TREATMENT Sports Injury Treatment

Non-surgical Regenerative TherapyPlatelet Rich Plasma TherapyAestheticsPhysiotherapy

Video TestimonialsWritten TestimonialsPodcast Testimonials

Am I a Candidate for Stem Cell Therapy? 10 Questions to Ask Yourself

Joint pain that limits daily life raises an obvious question. Is stem cell therapy a realistic option, or is it only for a narrow group of patients? A stem cell therapy assessment looks at your joint, your imaging, your medical history, and your goals together, not any single factor in isolation. This article walks through 10 questions used in real clinical screening, so you can work out where you likely stand before you ever pick up the phone.

What is a stem cell therapy candidacy assessment?

Knee pain without injury usually comes from a mechanical or biological process inside the joint that continues quietly between flare-ups. Rest reduces the irritation temporarily, but the underlying driver, whether it is cartilage thinning, muscle imbalance, or low-grade inflammation, is still active. Once normal activity resumes, so does the pain.

That distinction matters. Treating the flare-up without addressing what is generating it is why so many people describe the same cycle: pain, rest, short-term relief, and a return to square one within weeks.

Clinics do not offer stem cell therapy to every person who asks for it. Regenerative medicine works best within a defined clinical window, and outside that window the evidence for benefit weakens considerably. That is why every reputable provider, from academic centres to specialist clinics, runs candidates through a formal screening step before any treatment date is discussed.

The purpose of the assessment is not to gatekeep. It is to match the right treatment to the right joint at the right stage of disease. A patient with early-stage cartilage wear responds differently to treatment than someone with bone-on-bone changes, and an honest assessment protects both the patient’s money and their expectations.

Who Typically Qualifies for Stem Cell Therapy?

Across published clinical trials, eligibility criteria are more consistent than most patients expect. Trials registered on ClinicalTrials.gov for knee osteoarthritis commonly restrict enrolment to adults aged 40 to 80, with radiographic confirmation of Kellgren-Lawrence grade I to III changes on X-ray. Grade IV, where the joint space has collapsed almost completely, is frequently an exclusion criterion rather than an inclusion one.

What is the Kellgren-Lawrence grading system?

The Kellgren-Lawrence system is a 5-point scale, grade 0 to grade 4, used on X-rays to classify how much cartilage and joint space has been lost to osteoarthritis. Grade 0 means no changes, while grade 4 means severe, bone-on-bone joint damage.

Symptom scoring matters just as much as imaging. Trials frequently use the WOMAC index, a 24-item questionnaire covering pain, stiffness, and physical function, and set a minimum symptom threshold for inclusion. One allogeneic stem cell trial for knee osteoarthritis required a WOMAC score between 24 and 72, alongside confirmed Kellgren-Lawrence grade II or III changes and an age range of 40 to 75.

A retrospective 2-year study of mesenchymal stem cell therapy for osteoarthritis, published via the European Society of Medicine, included patients with a mean age over 65 and a body mass index of 30 or higher, and required confirmed osteoarthritis diagnosis with knee pain and restricted mobility. Patients who could not attend regular follow-up or who had dementia were excluded from that study.

In Ireland specifically, the scale of the underlying problem is significant. TILDA, the Irish Longitudinal Study on Ageing found an overall osteoarthritis prevalence of 12.9% in adults aged 50 and over, with a higher rate of 17.3% in women compared with 9.4% in men. Separate analysis of that data noted that one in five women and one in ten men over the age of 60 in Ireland carry a diagnosis of osteoarthritis, making knee and hip joint pain one of the most common reasons Irish patients research non-surgical alternatives.

10 Questions to Ask Yourself Before Booking a Consultation

These 10 questions mirror the areas a clinician will cover in a formal assessment. None of them replace a professional opinion, but working through them honestly will tell you whether a consultation is likely to be a good use of your time.

1. Which joint is affected, and is it your main source of pain?

Stem cell therapy for joint pain is most established for the knee, with a growing evidence base for the hip, shoulder, and ankle. If your pain is spread across multiple joints or linked to an inflammatory condition rather than mechanical wear, this changes the assessment considerably.

2. How long have you been dealing with this pain?

Most trial protocols require a documented history of joint pain lasting six months or longer. Pain that started days or weeks ago from an acute injury is usually assessed and treated differently to chronic, degenerative joint pain.

3. What non-surgical treatments have you already tried?

Clinicians want to see a documented trial of conservative options, such as physiotherapy, weight management, activity modification, or anti-inflammatory medication. This history helps confirm that simpler options have been reasonably exhausted first.

4. What does your imaging actually show?

An X-ray or MRI showing Kellgren-Lawrence grade I to III changes generally sits within the accepted treatment window. Grade IV, bone-on-bone disease, is where the evidence for stem cell therapy becomes far less certain, and joint replacement is often the more appropriate discussion.

5. Are you trying to delay or avoid joint replacement surgery?

Many patients researching knee osteoarthritis treatment are specifically hoping to buy time before a total knee or hip replacement. Stem cell therapy is generally positioned as a way to manage symptoms and function during that window, not as a permanent substitute for surgery in advanced disease.

6. Do you have any underlying health conditions?

Active infection at or near the joint, uncontrolled diabetes, active cancer, and certain autoimmune or bleeding disorders are common exclusion criteria across published trial protocols. A full medical history review is a required part of any responsible candidacy assessment.

7. Does your age fall within the typical treatment range?

Most published protocols enrol adults between 40 and 80 years old. This is not an arbitrary cut-off. It reflects the age range in which degenerative joint disease is common and where the underlying biology of the treatment has actually been studied.

8. What is your current activity level and realistic goal?

A generally active person who can walk without mobility aids fits the profile used in most trials, some of which specifically exclude patients who rely on wheelchairs or walking frames. Your goal, whether that is a return to hillwalking, gardening without pain, or simply managing stairs comfortably, shapes what a realistic outcome looks like.

9. Have you had a recent injection or joint procedure?

Many protocols require a gap of at least three months since your last corticosteroid or hyaluronic acid injection, and exclude any prior joint replacement surgery on the same joint. This history affects both eligibility and timing.

10. Are you prepared for a structured recovery and follow-up plan?

Regenerative treatments are not a single appointment with no aftercare. Most protocols involve a defined activity modification period and scheduled follow-up assessments, often using the same VAS pain scale and WOMAC scoring used before treatment, so that progress can be measured objectively rather than anecdotally.

Stem Cell Therapy for Arthritis: What the Evidence Shows

What are mesenchymal stem cells?

Mesenchymal stem cells, or MSCs, are cells found in bone marrow, fat tissue, and other sources that can develop into cartilage, bone, or connective tissue. In joint therapy, they are used for their ability to reduce local inflammation and support the joint’s own repair processes.

A systematic review and meta-analysis of randomised controlled trials for knee osteoarthritis found that mesenchymal stem cell implantation produced better outcomes in patients with Kellgren-Lawrence grade 3 disease compared with grade 4 disease, reinforcing that earlier-stage patients tend to see a stronger clinical response. The same body of evidence measured improvement using the Visual Analog Scale for pain and the International Knee Documentation Committee score, tracking patients out to 24 months.

What is the WOMAC index?

The WOMAC index is a 24-question survey that measures joint pain, stiffness, and physical function in patients with hip or knee osteoarthritis. Clinicians use WOMAC scores before and after treatment to track whether a patient’s symptoms are genuinely improving.

A global landscape review of interventional stem cell trials for osteoarthritis identified 224 eligible trials, with the number of studies increasing steadily and most focused on knee osteoarthritis using intra-articular, meaning directly into the joint, administration. This growing trial base is one reason the treatment landscape for stem cell treatment for arthritis has shifted from experimental to a defined, protocol-driven clinical option over the past decade.

At Medica Stem Cells, patients presenting with Grade 2 to 3 knee osteoarthritis who complete a full assessment and follow-up protocol are tracked using the same Oxford Knee Score and VAS pain measures referenced in published research, allowing genuine before-and-after comparison rather than a general impression of improvement.

When Stem Cell Therapy May Not Be Recommended

Honest candidacy assessment means acknowledging when stem cell therapy is not the right fit. Grade 4, bone-on-bone osteoarthritis with near-total joint space loss typically responds less predictably to regenerative treatment, and surgical options are usually discussed as the primary route in that scenario. Active joint infection, uncontrolled systemic disease, recent joint surgery on the same site, and certain cancer diagnoses are also common exclusion factors seen across clinical trial protocols.

This is also where platelet-rich plasma therapy sometimes enters the conversation, either as an alternative or as part of a combined protocol, depending on the specific joint and stage of disease identified during assessment.

Stem Cell Treatment Cost in Ireland: What Influences the Price

Patients searching for stem cell treatment Ireland cost or stem cell therapy near me are often trying to gauge affordability before booking a consultation. Cost genuinely varies based on several factors: the joint being treated, whether one or multiple joints require treatment, the specific cell source used, and whether imaging or additional diagnostics are needed as part of the assessment.

Because pricing depends on individual clinical findings rather than a flat rate, a proper cost estimate can only follow a candidacy assessment, not precede it. Patients in Dublin and across Ireland researching stem cell treatment Dublin options should expect an initial consultation fee that is separate from any subsequent treatment cost, and should be wary of any provider quoting a fixed price without first reviewing imaging and medical history.

Frequently Asked Questions:

The clearest way to know is a formal clinical assessment covering your joint imaging, symptom duration, prior treatments, and overall health. The 10 questions above give a strong early indication, but only a clinician reviewing your specific case can confirm candidacy.

Generally, no. Most published evidence and trial eligibility criteria focus on Kellgren-Lawrence grade I to III disease. Grade 4, bone-on-bone changes typically respond less predictably, and surgical options are usually the more appropriate discussion at that stage.

For many patients with earlier-stage osteoarthritis, stem cell therapy is used to manage pain and function and to potentially delay the need for joint replacement. It is not positioned as a guaranteed permanent alternative to surgery in advanced disease.

Cost depends on the joint treated, the cell source used, and the diagnostics required, so it cannot be accurately quoted before a clinical assessment. A consultation will typically identify these variables and provide a personalised estimate.

Stem cell therapy uses cells capable of supporting tissue repair and reducing inflammation, while platelet-rich plasma therapy uses concentrated platelets from your own blood to stimulate healing through growth factors. Some patients are suited to one, the other, or a combined protocol, depending on their specific joint and stage of disease.

Conclusion

Working through these 10 questions will not replace a clinical opinion, but it gives you a realistic starting point. If your joint pain has lasted more than six months, conservative treatments have not given you lasting relief, and your imaging sits within the grade I to III range, you likely fall within the group that clinical evidence supports most strongly. The next honest step is a proper assessment, not a guess based on a symptom checklist alone. Book a consultation with our clinical team to find out where you actually stand.

This article is for informational purposes only and does not constitute medical advice. Individual results may vary. Please consult a qualified clinician before making any treatment decisions.